中国科学院动物研究所是以动物科学基础研究为主的社会公益型国家级科研机构，开展现代动物学研究，服务于人口健康、农业和生物多样性保护等国家重大需求。
历史悠久：成立于 1928 年，至今已有 97 年的历史
大师云集：曾产生过 16 位中国科学院学部委员（院士）
深厚积淀：作为第一完成单位共有 28 项成果获得全国科学大会奖、国家自然科学奖、国家发明奖、国家科学技术进步奖等国家科学技术奖励
人才队伍：现有研究组长 88 人，其中，中国科学院院士 4 人，国家杰出青年科学基金项目获得者 28 人，国家优秀青年科学基金项目获得者 21 人，国家引才计划青年项目获得者 28 人
动物研究所在干细胞与再生医学领域发挥引领作用：
科研引领：取得揭示干细胞干性与功能调控机制等一批高水平研究成果，11 次入选中国科学或中国生命科学十大进展；积极承担国家重大科研任务，牵头国家重点研发计划等重大项目 28 项、国家自然科学基金委基础科学中心项目 2 项、创新研究群体项目 4 项
行业引领：开发系列干细胞及基因编辑底层技术，研发我国首个多能干细胞药物，处于国际领先水平；发布干细胞领域首个国际标准，保障领域平稳发展；积极推动科研成果转移转化，获得授权专利百余项、与企业达成技术合同额超过 10 亿元
范式引领：与知名国际药企建立深度合作，建立国际合作范式；牵头成立自主研发基金，发展多元科研资助与评价体系；牵头成立国际干细胞组织，促进干细胞转化国际协作
学科引领：承办中国科学院大学医学院，并首次设置再生医学交叉学科（2016 年）以及生物医学工程学科（2023 年）
新的历史时期，在干细胞与再生医学领域，动物研究所承担多个重要国家级平台建设任务，包括国家重大科技基础设施人类器官生理病理模拟装置（以下简称 「HOPE 装置 」）、器官再生与智造全国重点实验室以及国家级科技资源共享服务平台国家干细胞资源库。
HOPE 装置是国家发改委批复的 「 十四五 」 国家重大科技基础设施，通过多学科交叉，以 「 造元件、组系统、仿功能 」 为建设思路，将建成能在整体水平、人群规模模拟人体生理和病理过程、具有国际领先水平的大型综合装置，为生命科学、药物评价、再生医学等提供开放式、场景化的研究平台，带动生物医药领域变革，服务于生命科学、人口健康和社会经济发展。
根据 HOPE 装置的建设规划，结合其前沿交叉的特点，现面向全球招聘研究员（高层次引进人才），欢迎有志参与国家重大科技设施建设的工程技术类人才和探索生命健康领域前沿的自然科学类人才加入 HOPE 装置建设团队，从事包括但不限于组织再生与器官构建、生物传感与器官芯片、疾病机理与药物筛评、数字化器官、生物医学仪器研发等领域方向，探索新兴的跨学科研究方向，推动干细胞与再生医学的应用以及器官制造领域的发展，服务于人民健康和生物医药产业的国家重大需求。
招聘方向：类器官、器官芯片、生物医学工程、生物制造、生物医学成像、自动化、生物计算、人工智能、生物力学、机械电子等交叉学科方向
招聘条件：具有博士学位，在上述相关领域取得国际领先的科研成果， 具有较大发展潜力以及较强交叉学科背景，能够作为科研骨干支撑 HOPE 装置建设任务
科研保障：中国科学院战略性先导科技专项依托单位以及国家重点研发计划干细胞重点专项规划单位；已运行近 10 亿元科研仪器平台以及正在建设近 30 亿元科研仪器平台 ；国际一流的模式生物、啮齿类、小型猪及灵长类动物基地；遍布全国的临床资源合作网络及转化研究平台；专业技术与管理团队支持，提供从基础研究到成果转化的全链条服务
个人待遇：支持申报国家、中国科学院、北京市高层次人才项目，入选国家或中国科学院领军人才项目，可获得千万元以上科研启动经费支持，入选优青（海外）项目或中国科学院青年项目，均可获得 800-1000 万元科研启动经费；提供具有国际竞争力的个人薪酬和安居费（购房补贴），购房前提供交通便利、配套齐全的人才周转住房 1 套，特别优秀者 「 一事一议 」；享受公费医疗，根据北京市政策解决本人、配偶及子女北京户口，协助解决子女入园入学等
有意者请将个人简历通过 E-mail 提交，邮件命名为 「HOPE 研究员应聘+姓名 」。
联系邮箱：hope@ioz.ac.cn
如需了解更多，可访问动物研究所主页：http://www.ioz.cas.cn
Gathering Brilliance, Sparking Hope, Transforming Lives!
HOPE Facility: Global Recruitment for Top-Tier Talent
-- Institute of Zoology, Chinese Academy of Sciences (CAS)
The Institute of Zoology, Chinese Academy of Sciences, is a national-level research institution dedicated to fundamental research in zoological sciences. It focuses on modern zoological studies to address major national needs, including population health, agriculture, and biodiversity conservation.
Rich History: Established in 1928, the institute boasts a 97-year legacy.
Eminent Scholars: Home to 16 members of the Chinese Academy of Sciences (Academicians).
Profound Achievements: As the primary completing unit, the institute has been awarded 28 national scientific honors, including prizes from the National Science Conference Award, the National Natural Science Award, the National Invention Award, and the National Science and Technology Progress Award.
Talented Team: The institute currently has 88 research group leaders, including 4 CAS Academicians, 28 recipients of the National Science Fund for Distinguished Young Scholars, 21 recipients of the National Science Fund for Excellent Young Scholars, and 28 recipients of the National Young Talent Recruitment Program.
The Institute of Zoology plays a leading role in the field of stem cell and regenerative medicine:
Leadership in Scientific Research: Achieved high-level research results revealing mechanisms of stem cell pluripotency and function regulation. These accomplishments have been recognized 11 times in China's Top 10 Advances in Science or Life Sciences.
Actively undertaken major national research tasks, leading 28 key projects under the National Key Research and Development Program of China, 2 Basic Science Center Projects and 4 Innovative Research Group Projects from the National Natural Science Foundation of China (NSFC).
Leadership in Industry Development: Developed a series of foundational technologies in stem cells and gene editing, and pioneered China's first pluripotent stem cell drug, achieving international leading levels. Published the first international standard in the stem cell field, ensuring stable development of the discipline. Actively promoted the transformation of scientific research achievements, securing over 100 authorized patents, and signing technology contracts with enterprises exceeding 1 billion RMB.
Leadership in Paradigm Innovation: Established in-depth collaborations with renowned international pharmaceutical companies, setting a model for international collaboration. Led the establishment of an independent R&D fund, developing diverse scientific research funding and evaluation systems. Initiated the formation of an international stem cell organization to promote global collaboration in stem cell translation.
Leadership in Academic Disciplines: Hosted the School of Medicine at the University of Chinese Academy of Sciences (UCAS), and pioneered the establishment of interdisciplinary programs in regenerative medicine (2016) and biomedical engineering (2023).
In this new historical period, the Institute of Zoology has undertaken several critical national platform construction tasks in the field of stem cells and regenerative medicine. These include:
1) Major National Science and Technology Infrastructure: Human Organ Physiopathology Emulation System (hereinafter referred to as the "HOPE Facility」)
2) State Key Laboratory of Organ Regeneration and Reconstruction.
3) National-Level Science and Technology Resource Sharing Service Platform: National Stem Cell Resource Center (NSCRC)
The HOPE Facility, approved by the National Development and Reform Commission as a major national science and technology infrastructure under the 14th Five-Year Plan, follows a multidisciplinary approach with the construction concept of "building components, assembling systems, and simulating functions." It aims to establish a large-scale, comprehensive facility capable of simulating human physiological and pathological processes at the overall level and on a population scale, reaching international leading levels. This facility will provide an open and scenario-based research platform for life sciences, drug evaluation, regenerative medicine, and other fields, driving innovation in the biopharmaceutical industry and serving life sciences, population health, and socioeconomic development.
In line with the construction plan of the HOPE Facility and its cutting-edge interdisciplinary nature, we are now globally recruiting researchers (high-level talents). We welcome talented individuals in engineering and technology who are interested in participating in the construction of major national science and technology infrastructure, as well as natural science talents exploring the frontiers of life and health. The HOPE Facility construction team invites you to join us in fields including, but not limited to, tissue regeneration and organ construction, biosensing and organ-on-a-chip, disease mechanisms and drug screening, digital organs, biomedical instrument development, and other emerging interdisciplinary research directions. Together, we will explore emerging interdisciplinary research directions, promote the application of stem cells and regenerative medicine, and advance the development of organ manufacturing, addressing major national needs in public health and the biopharmaceutical industry.
Recruitment Directions: Organoids, Organs-on-chips, Biomedical Engineering, Biofabrication, Biomedical Imaging, Automation, Bioinformatics, Artificial Intelligence, Biomechanics, Mechatronics, and other interdisciplinary fields.
Recruitment Requirements: Hold a doctoral degree and have achieved internationally leading scientific research results in the aforementioned related fields.Demonstrate significant potential for development and possess a strong interdisciplinary background.Capable of serving as a key research backbone to support the construction tasks of the HOPE Facility.
Research Support: Affiliated with the Chinese Academy of Sciences (CAS) Strategic Priority Research Programs and the National Key R&D Program for Stem Cell Research; operating a scientific research instrument platform worth nearly 1 billion RMB and constructing another platform worth nearly 3 billion RMB; world-class model organisms facilities, including rodents, mini pigs, and primates; extensive clinical resource cooperation network and translational research platform nationwide; professional technical and management team support providing full-chain services from basic research to achievement transformation.
Personal Benefits: Support for applying to national, CAS, and Beijing high-level talent programs; selected candidates for national or CAS leading talent programs may receive over 10 million RMB in research start-up funding; selected candidates for the Excellent Young Scientists (Overseas) projects or CAS youth projects may receive 8-10 million RMB in start-up research funding.
Providing internationally competitive salary and housing allowances (home purchase subsidies); provision of conveniently located, fully equipped transitional housing before home purchase.
Coverage under public medical insurance; assistance with Beijing household registration (hukou) for the candidate, spouse, and children, in accordance with Beijing policies; support for children’s enrollment in kindergarten and school.
Please submit your CV via email, with the subject line "HOPE Researcher Application + Your Name."
Contact Email: hope@ioz.ac.cn
For more information, please visit the Institute of Zoology's website: http://www.ioz.cas.cn
